Alvarez-Sala JL - Search Results

1

Chronic respiratory symptoms, spirometry and knowledge of COPD among general population.

Miravitlles M, de la Roza C, Morera J, Montemayor T, Gobartt E, Martín A, Alvarez-Sala JL. Miravitlles M, et al. Respir Med. 2006 Nov;100(11):1973-80. doi: 10.1016/j.rmed.2006.02.024. Epub 2006 Apr 12. Respir Med. 2006. PMID: 16626950 Free article.

2

The general public's knowledge of chronic obstructive pulmonary disease and its determinants: current situation and recent changes.

Soriano JB, Calle M, Montemayor T, Alvarez-Sala JL, Ruiz-Manzano J, Miravitlles M. Soriano JB, et al. Arch Bronconeumol. 2012 Sep;48(9):308-15. doi: 10.1016/j.arbr.2012.07.001. Epub 2012 Jun 29. Arch Bronconeumol. 2012. PMID: 22748482 English, Spanish.

3

[Effect of AM3 on health-related quality of life in patients with chronic obstructive pulmonary disease belonging to risk groups].

Miravitlles M, Murio C, Morera J, Callol L, Alvarez-Sala JL, Alvarez-Mon M. Miravitlles M, et al. Med Clin (Barc). 2008 May 17;130(18):688-92. doi: 10.1157/13120769. Med Clin (Barc). 2008. PMID: 18501139 Clinical Trial. Spanish.

4

Treatment with the immunomodulator AM3 improves the health-related quality of life of patients with COPD.

Alvarez-Mon M, Miravitlles M, Morera J, Callol L, Alvarez-Sala JL. Alvarez-Mon M, et al. Chest. 2005 Apr;127(4):1212-8. doi: 10.1378/chest.127.4.1212. Chest. 2005. PMID: 15821197 Clinical Trial.

5

Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.

Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R; IMPAC Study Group. Miravitlles M, et al. Thorax. 2004 May;59(5):387-95. doi: 10.1136/thx.2003.008730. Thorax. 2004. PMID: 15115864 Free PMC article.

6

[Residency training of European respiratory medicine specialists: The HERMES project].

Tirado-Conde G, Miravitlles M, Alvarez-Sala JL, de Castro FR, Ancochea J. Tirado-Conde G, et al. Arch Bronconeumol. 2009 Feb;45(2):92-9. doi: 10.1016/j.arbres.2008.05.002. Arch Bronconeumol. 2009. PMID: 19232271 Spanish.

7

Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study.

Miravitlles M, Zalacain R, Murio C, Ferrer M, Alvarez-Sala JL, Masa JF, Verea H, Ros F, Vidal R; IMPAC Study Group (see page 448). Miravitlles M, et al. Clin Drug Investig. 2003;23(7):439-50. doi: 10.2165/00044011-200323070-00003. Clin Drug Investig. 2003. PMID: 17535055

8

Treatment and quality of life in patients with chronic obstructive pulmonary disease.

Miravitlles M, Alvarez-Sala JL, Lamarca R, Ferrer M, Masa F, Verea H, Zalacain R, Murio C, Ros F; IMPAC Study Group. Miravitlles M, et al. Qual Life Res. 2002 Jun;11(4):329-38. doi: 10.1023/a:1015520110663. Qual Life Res. 2002. PMID: 12086118

9

[Pneumologists: Where are we going and where have we come from?].

Miravitlles M, Rodríguez De Castro F, Agustí A, Alvarez-Sala JL; Comisión Nacional de Neumoligía. Miravitlles M, et al. Arch Bronconeumol. 2002 Jul;38(7):334-5. doi: 10.1016/s0300-2896(02)75228-9. Arch Bronconeumol. 2002. PMID: 12199934 Spanish. No abstract available.

10

Health literacy and health outcomes in chronic obstructive pulmonary disease.

Puente-Maestu L, Calle M, Rodríguez-Hermosa JL, Campuzano A, de Miguel Díez J, Álvarez-Sala JL, Puente-Andues L, Pérez-Gutiérrez MJ, Lee SY. Puente-Maestu L, et al. Respir Med. 2016 Jun;115:78-82. doi: 10.1016/j.rmed.2016.04.016. Epub 2016 Apr 27. Respir Med. 2016. PMID: 27215508 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page